A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2011
11/16/2011	CN102240384A Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof
11/16/2011	CN102240380A Traditional Chinese medicine preparation for treating senile vascular dementia
11/16/2011	CN102240374A Forgetfulness-preventing intelligence-promoting cerebral tonic pill for children
11/16/2011	CN102240340A Method for processing prepared rehmannia root
11/16/2011	CN102240334A Traditional Chinese medicine for treating insomnia
11/16/2011	CN102240328A Traditional Chinese medicine for treating cold and preparation method thereof
11/16/2011	CN102240311A Application of pseudo-ginseng triol saponin to preparation of medicament for preventing and treating neurodegenerative disease
11/16/2011	CN102240307A Preparation method of ginkgo leaf extract
11/16/2011	CN102240289A Pharmaceutical composition containing flibanserin polymorph a
11/16/2011	CN102240287A Applications of gelsemine, koumine and 1-methoxyl gelsemine to preparation of medicine for treating anxiety
11/16/2011	CN102240281A Application of 5'-methoxy-3',4'-methylenedioxy cinnamic acid isobutyl amide in preparing antidepressant medicaments
11/16/2011	CN102240279A Piglet soothing agent and preparation method and application thereof
11/16/2011	CN102240278A Methods, assays and compositions for treating retinol-related diseases
11/16/2011	CN102240274A Application of magnolol and honokiol in protein tyrosine phosphatase 1B inhibitor
11/16/2011	CN102240270A Blonanserin tablet and preparation method thereof
11/16/2011	CN102240263A Tiapride hydrochloride injection and preparation method thereof
11/16/2011	CN102240125A Nerve-soothing tendon-relaxing neck pillow
11/16/2011	CN102008674B Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof
11/16/2011	CN101972310B Anti-anxiety medicine by using rheum officinate root extract as active ingredient, and method and application thereof
11/16/2011	CN101934115B Health bamboo vinegar paste
11/16/2011	CN101926911B Chinese medicinal composition for relieving pain and preparation method thereof
11/16/2011	CN101837024B Quick-acting medicament for curing tic disorder disease
11/16/2011	CN101780185B Health wine for promoting sexual function
11/16/2011	CN101716262B Extract from Iris tenuifolia, preparation method and application thereof
11/16/2011	CN101703615B Chinese medicinal composition for treating insomnia
11/16/2011	CN101683407B Traditional Chinese medicine compound preparation for treating insomnia and preparation method thereof
11/16/2011	CN101563344B Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/16/2011	CN101513517B Traditional Chinese medicine electuary for treating parkinson disease and senile dementia
11/16/2011	CN101468069B Compound long pepper pain-relieving capsule
11/16/2011	CN101411833B Dragon's blood extract as well as preparation method and application thereof
11/16/2011	CN101406474B Nalmefene injection and preparation method thereof
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/16/2011	CN101330915B Pharmaceutical compositions containing Erythrine mulungu derivatives and processes for their production
11/16/2011	CN101317867B Application of standard extract of pseudo-ginseng in preparing medicament for preventing and controlling senile dementia
11/16/2011	CN101305004B Novel diazabicyclic aryl derivatives and their medical use
11/16/2011	CN101103112B Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
11/16/2011	CN101084227B Rapamycin analogues and the uses thereof in the treatment of neurological disorders, proliferative diseases and inflammatory disease
11/16/2011	CN101011450B Quality control method for lucid ganoderma gynostemma pentaphylla oral liquid
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058425 Purine derivatives as kinase inhibitors
11/15/2011	US8058305 Pyrrolidine derivatives as prostaglandin modulators
11/15/2011	US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011	US8058283 7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058280 Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
11/15/2011	US8058277 Substituted indoles
11/15/2011	US8057811 Stable clozapine suspension formulation
11/15/2011	US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2469612C Treatment of statin side effects using uridine derivatives
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/15/2011	CA2318392C Mammalian appeasing pheromones to decrease stress, anxiety and aggressiveness
11/10/2011	WO2011140431A1 Varenicline salts and crystal forms thereof
11/10/2011	WO2011140425A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/10/2011	WO2011140249A2 Antibodies that bind csf1r
11/10/2011	WO2011140198A2 Compounds and methods of treating brain disorders
11/10/2011	WO2011139992A1 Aromatic-cationic peptides and uses of same
11/10/2011	WO2011139951A1 Modulators of fatty acid amide hydrolase
11/10/2011	WO2011139811A1 Nicotine-containing pharmaceutical compositions
11/10/2011	WO2011139752A2 Preparation of polypeptides and salts thereof
11/10/2011	WO2011139079A2 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011	WO2011138293A1 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
11/10/2011	WO2011138266A1 Indolizine and imidazopyridine derivatives as orexin receptor antagonists
11/10/2011	WO2011138265A2 Indole and indazole derivatives as orexin receptor antagonists
11/10/2011	WO2011137886A1 Agents for treating alzheimer's disease
11/10/2011	WO2011137511A1 Compounds, compositions and methods for treatment of central nervous system injuries
11/10/2011	WO2011137491A1 Novel drug delivery system
11/10/2011	WO2011112893A9 Compositions for ameliorating cell proliferative disorders and methods of making and using them
11/10/2011	WO2011090740A3 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/10/2011	WO2011084433A3 Aza-bridged ring-fused indoles and indolines
11/10/2011	WO2011084025A3 Hexane extract
11/10/2011	WO2011082283A9 Management of myoclonus with oral liposomal reduced glutathione
11/10/2011	WO2011065769A3 Cell or culture extract of cladonia macilenta purple and/or biruloquinone as acetylcholinesterase inhibitors
11/10/2011	WO2011059263A3 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/10/2011	WO2011008274A4 Reduced volume formulation of glatiramer acetate and methods of administration
11/10/2011	US20110275719 Novel trifluoromethylsulfonamide gamma secretase inhibitor
11/10/2011	US20110275718 Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same
11/10/2011	US20110275695 Crystalline forms of zotepine hydrochloride
11/10/2011	US20110275693 Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
11/10/2011	US20110275691 Methods of treating headaches using 5-ht agonists in combination with long-acting nsaids
11/10/2011	US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011	US20110275683 Selenophene and Selenazole Carboxylic Acid Derivatives
11/10/2011	US20110275682 Novel choline cocrystal of epalrestat
11/10/2011	US20110275681 Novel solid forms of epalrestat
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275674 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275664 Method for treating drug and behavioral addictions
11/10/2011	US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
11/10/2011	US20110275660 Beta carboline sulphonylurea derivatives as ep4 receptor antagonists
11/10/2011	US20110275658 Opioid-containing oral pharmaceutical compositions and methods
11/10/2011	US20110275650 Methods and compositions related to targeting monoacylglycerol lipase
11/10/2011	US20110275642 New method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 1833